Legal & General Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,118
Closed -$18.3K 3540
2024
Q1
$18.3K Hold
7,118
﹤0.01% 3001
2023
Q4
$14.5K Sell
7,118
-1,325
-16% -$2.42K ﹤0.01% 3155
2023
Q3
$14.6K Hold
8,443
﹤0.01% 3160
2023
Q2
$16.5K Buy
+8,443
New +$19.8K ﹤0.01% 3191
2022
Q2
Sell
-3,478
Closed -$14K 3692
2022
Q1
$14K Hold
3,478
﹤0.01% 3329
2021
Q4
$45K Buy
3,478
+253
+8% +$2.8K ﹤0.01% 3053
2021
Q3
$35K Hold
3,225
﹤0.01% 3079
2021
Q2
$29K Buy
3,225
+646
+25% +$5.97K ﹤0.01% 3155
2021
Q1
$24K Sell
2,579
-261
-9% -$3.59K ﹤0.01% 3061
2020
Q4
$11K Hold
2,840
﹤0.01% 3318
2020
Q3
$8K Sell
2,840
-1,169
-29% -$4.34K ﹤0.01% 3321
2020
Q2
$27K Buy
4,009
+512
+15% +$3.45K ﹤0.01% 2940
2020
Q1
$20K Sell
3,497
-876
-20% -$7.36K ﹤0.01% 2919
2019
Q4
$39K Buy
4,373
+217
+5% +$1.81K ﹤0.01% 2924
2019
Q3
$36K Hold
4,156
﹤0.01% 2884
2019
Q2
$42K Buy
4,156
+3,086
+288% +$35.3K ﹤0.01% 2846
2019
Q1
$14K Hold
1,070
﹤0.01% 3193
2018
Q4
$17K Buy
+1,070
New +$20.4K ﹤0.01% 3151

Other funds holding GRTS

Legal & General Group's GRTS Position: Q2 2024 in Review

Legal & General Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 7,118 shares — an estimated $18.3K sold.

Legal & General Group first reported a position in GRTS in Q4 2018 and held it in 18 quarters. The position peaked at $45K in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • Legal & General Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 7,118 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $18.3K.
  • Legal & General Group first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 18 quarters.
  • Legal & General Group's Gritstone bio, Inc. Common Stock position peaked at $45K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.